Author

Martin Weber

Genentech

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Alicia A. Nugent· 1 shared Amber L. Cramer· 1 shared Anjani Ganti· 1 shared Anton Delwig· 1 shared Brett M. BabiniD· 1 shared Bryan Chan· 1 shared Casper C. HoogenraadiD· 1 shared Chang Hoon ChoiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alicia A. Nugent

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Complement C3aR deletion does not attenuate neurodegeneration in a tauopathy model or alter acute inflammation-induced gene expression changes in the brain

Yuanyuan Wang, Shristi Pandey, Martin Weber, Man Kin Choy, Tiffany Z. Wu, Tania Chernov-Rogan, Hai Ngu, Oded Foreman, Luke Xie, Jesse E. Hanson

This study shows that deleting C3aR does not reduce neurodegeneration in a tauopathy model or alter gene expression changes during acute inflammation.

bioRxiv · Jun 16, 2025 · PreprintNeuroscience

SARM1 orthosteric base exchange inhibitors cause subinhibitory SARM1 activation

Rebecca Leahey, Martin Weber, Chang Hoon Cho, Seong Kwon Hur, Amber L. Cramer, Karla Manzanares, Brett M. Babin, Gladys de Leon Boenig, Taylor Kring, Liling Liu, Yusi Cui, Anjani Ganti, John P. Evans, Marika Nespi, Justin Ly, , Flora I. Hinz

The paper shows that subinhibitory concentrations of orthosteric SARM1 inhibitors can activate SARM1, leading to NAD consumption, neurodegeneration, and biomarker release in neurons.

bioRxiv · Aug 6, 2024 · PreprintNeuroscience